Ticker Symbol: FRLN
Freeline Therapeutics Holdings plc - ADR
$2.85 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
United Kingdom
Currency:
USD
Asset
Type: ADR
CIK:0001810031
Company Profile
Freeline Therapeutics Holdings PLC operates as a biotechnology company. The Company focuses on developing liver directed gene therapies for bleeding disorders and other debilitating chronic diseases. Freeline Therapeutics serves patients worldwide.
Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Standard Industrial Classification Code (SIC code): 2836
Address: Stevenage Bioscience Catalyst
Website: www.freeline.life
CEO: N/A
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Biological Product (except Diagnostic) Manufacturing
Pricing
Last Updated: October 13, 2023 03:00 PM EST
Previous Close: $3.63
Change:
$0.45
(
14.15%)
Days Range: $3.03 - $3.65
Beta: 0.91
52wk. High: $12.00
52wk. Low: $2.11
Ytd. Change -34.91%
50 Day Moving Average: $3.82
200 Day Moving Average: $3.90
Shares Outstanding: 2432290
Valuation
Market Cap: 882.9M
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A